Type 2 diabetes is one of the most common long-term health conditions in the world. It happens when the body cannot use insulin properly. Insulin is a hormone that helps move sugar from the blood into the body’s cells, where it is used for energy.
When the body becomes resistant to insulin or does not produce enough of it, sugar builds up in the bloodstream. Over time, high blood sugar can damage many parts of the body, including the heart, kidneys, eyes, and nerves.
For many people diagnosed with Type 2 diabetes, the first medicine doctors prescribe is metformin. Metformin has been used for decades and is considered a reliable and effective treatment. It works mainly by lowering the amount of sugar the liver releases into the blood and by helping the body respond better to insulin.
For a large number of patients, metformin can control blood sugar levels well, especially when combined with healthy eating and regular physical activity.
However, Type 2 diabetes is a progressive condition. This means that over time the body may become less responsive to treatment. For some patients, metformin alone is no longer enough to keep blood sugar at a healthy level. When this happens, doctors often need to add other medications to help control the disease.
Researchers from Thomas Jefferson University have recently found encouraging results from a study looking at two diabetes medicines used together. The medications are called dapagliflozin and exenatide.
According to the scientists, combining these two drugs may provide stronger and longer-lasting control of blood sugar for people whose diabetes is not well managed with metformin alone.
The research team studied 695 adults with Type 2 diabetes. All of the participants were already taking metformin, but their blood sugar levels were still higher than recommended. The scientists wanted to see how adding different medicines would affect their health over time.
The participants were divided into three groups. One group received exenatide, which is given as a weekly injection. Another group took dapagliflozin as a daily pill. The third group received both exenatide and dapagliflozin in addition to their regular metformin treatment.
The researchers followed the participants for two years to see how their blood sugar levels changed.
After analyzing the results, the scientists found that people who used both medications together had better control of their blood sugar compared with those who used only one of the additional drugs. The improvement was not only stronger but also lasted longer throughout the study period.
One reason the combination worked so well is that the two medicines help the body in different ways. Dapagliflozin works through the kidneys. It helps the body remove extra sugar from the blood by passing it into the urine. This process lowers blood sugar levels without relying heavily on insulin.
Exenatide works differently. It helps the body release more insulin after meals, when blood sugar usually rises. It also slows the speed at which food leaves the stomach, which helps prevent sudden spikes in blood sugar.
In addition, exenatide reduces the amount of sugar the liver produces and can help people feel full longer. Because people feel satisfied sooner, they may eat less, which can lead to gradual weight loss.
When these two medicines are used together, their effects complement each other. In the study, participants taking both drugs experienced better blood sugar control than those taking either medication alone.
The combination treatment also provided additional health benefits. Many participants lost weight and saw improvements in their blood pressure. Both weight control and healthy blood pressure are very important for people living with Type 2 diabetes because they reduce the risk of heart disease and other complications.
Another encouraging finding from the study was the safety of the treatment. During the two-year research period, the scientists did not observe any unexpected safety concerns. The medications were generally well tolerated by the participants.
The study’s lead researcher, Dr. Serge Jabbour from Thomas Jefferson University, believes the findings could help doctors treat diabetes more effectively. For patients whose blood sugar remains high despite taking metformin, this combination therapy could offer a powerful new option.
Managing Type 2 diabetes often requires long-term strategies that go beyond a single medication. Doctors usually recommend a combination of treatments, including medicines, healthy eating, exercise, and regular monitoring of blood sugar levels.
The discovery that dapagliflozin and exenatide work especially well together may give doctors another tool to help patients maintain better control of their condition.
The findings of this research were published in the journal Diabetes Care. The results suggest that combining medications that work in different ways may be an effective approach to managing complex diseases like Type 2 diabetes.
For the millions of people around the world living with diabetes, this research offers hope. It shows that new treatment strategies can improve blood sugar control while also supporting overall health. As scientists continue to study better ways to manage diabetes, patients may benefit from treatments that are more effective, longer lasting, and tailored to their needs.
If you care about diabetes, please read studies about 5 vitamins that may prevent complication in diabetes, and how to manage high blood pressure and diabetes with healthy foods.
For more health information, please see recent studies about vitamin D and type2 diabetes, and to people with type 2 diabetes, some fruits are better than others.
Copyright © 2026 Knowridge Science Report. All rights reserved.
